Summary
Lam Research Corporation (LRCX) reported financial results for the quarter ended December 25, 2011. The company experienced a notable decline in revenue and gross margin compared to the prior year, reflecting a slowdown in semiconductor capital equipment spending due to macroeconomic conditions. Despite the challenging environment, Lam Research continued to invest in research and development and announced a significant strategic move with the planned acquisition of Novellus Systems, Inc., valued at approximately $3.3 billion, which aims to enhance its product and service portfolio. The company maintained a strong liquidity position with approximately $2.4 billion in cash, cash equivalents, and short-term investments. However, the report highlights the cyclical nature of the semiconductor industry and the inherent uncertainty in forecasting future demand, suggesting potential volatility in quarterly results. Investors should monitor the progress of the Novellus acquisition and its integration, as well as the company's ability to navigate the cyclical industry downturns.
Financial Highlights
52 data points| Revenue | $583.98M |
| Cost of Revenue | $349.15M |
| Gross Profit | $234.83M |
| R&D Expenses | $104.02M |
| SG&A Expenses | $83.26M |
| Operating Expenses | $187.28M |
| Operating Income | $47.55M |
| Interest Expense | $9.35M |
| Net Income | $33.21M |
| EPS (Basic) | $0.03 |
| EPS (Diluted) | $0.03 |
| Shares Outstanding (Basic) | 1.20B |
| Shares Outstanding (Diluted) | 1.21B |
Key Highlights
- 1Revenue for the quarter ended December 25, 2011, was $583.98 million, a decrease of 33% year-over-year, reflecting a slowdown in customer investments.
- 2Gross margin decreased to 40.2% from 46.8% in the prior year's quarter, primarily due to lower factory utilization rates and product mix.
- 3The company announced a significant strategic agreement to acquire Novellus Systems, Inc. for approximately $3.3 billion in an all-stock transaction, aiming to expand its offerings.
- 4Lam Research maintained a strong liquidity position, with $2.4 billion in cash, cash equivalents, and short-term investments as of December 25, 2011.
- 5Operating expenses increased compared to the prior year's quarter, driven by R&D investments and acquisition-related costs for the Novellus deal.
- 6Net income significantly declined year-over-year to $33.2 million ($0.27 per diluted share) from $221.8 million ($1.78 per diluted share).
- 7The company continued to repurchase shares under its authorized program, with an increased repurchase authorization of up to $1.6 billion announced in December 2011.